research use only
Cat.No.S4152
| Related Targets | CXCR Hedgehog/Smoothened PKA Adrenergic Receptor AChR 5-HT Receptor Histamine Receptor Dopamine Receptor Ras KRas |
|---|---|
| Other Prostaglandin Receptor Inhibitors | PF-04418948 TG4-155 E7046 (ER-886406) Grapiprant (CJ-023,423) Timapiprant Sodium Seratrodast(AA-2414) BI-671800 Setipiprant (ACT-129968) Terutroban Genz-123346 free base |
|
In vitro |
DMSO
: 53 mg/mL
(201.28 mM)
Water : 53 mg/mL Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 263.31 | Formula | C6H6O5S.C4H11N |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 2624-44-4 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | Etamsylate | Smiles | CCNCC.C1=CC(=C(C=C1O)S(=O)(=O)O)O | ||
| Targets/IC50/Ki |
prostaglandins
|
|---|---|
| In vitro |
Ethamsylate inhibits prostaglandin bio-synthesis in microsomes of pregnant human myometrium with IC50 of 0.5 mM. This compound is particularly active against hydroxyl radicals (OH.), which are scavenged at therapeutic concentrations (0.1–10 μM). Higher concentrations are required to scavenge superoxide radicals. It potentiates human platelet aggregation and ATP release induced by arachidonic acid, thromboxane A2, collagen, and calcium ionophore A23187.
|
| In vivo |
Ethamsylate reduces the mean bleeding time when administered systemically or orally to rabbits. By the intravenous route, this compound reduces bleeding time by half at doses >5 mg/kg. The effect starts 5 minutes after the injection, reaches a maximum between 30 minutes and 4 hours after the injection, and disappears after 6 hours. By the oral route, a similar maximal action is observed at the dose of 10 mg/kg. The efficacy of this chemical to reduce intraventricular hemorrhage is associated with a reduction of thromboxane A2 and prostacyclin biosynthesis. Orally given Ethamsylate (>25 mg/kg) also inhibits carrageenan-induced rat paw edema.
|
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.